Navigation Links
Global Pharmaceutical Leader Chooses Acsis Enterprise Serialization Management Suite to Achieve e-Pedigree Compliance

MARLTON, N.J., April 9, 2013 /PRNewswire/ -- Acsis Inc., the market leader for Enterprise Serialization solutions, today announced Daiichi Sankyo, Inc. selected the Acsis Serialization Management Suite to comply with FDA e-pedigree mandates and other federal regulations. The turnkey solution includes the Acsis proven serialization management solution with best-of-breed vision and printing equipment from Cognex and Domino. Daiichi Sankyo will install this turnkey solution initially as a pilot at the company's packaging plant in Bethlehem, PA, with Acsis managing all aspects of implementation and support. 

The Acsis serialization solution for Daiichi Sankyo ensures the protection of the company's pharmaceutical supply chain against a variety of issues such as counterfeit, diverted, substandard, adulterated, misbranded and/or expired medications. Acsis' serialization solution includes Line Management, Site Management and Serial Aggregation Management capabilities. Collectively, this suite of solutions will ensure compliance with state and federal laws, including:

  • Automating and managing the application of serialized codes on packaging lines
  • Tracking and controlling all parent-to-child relationships
  • Providing real-time access to real-time and historical posting reports, reconciliation reports and serial number status reports
  • Supporting commissioning, de-commissioning, aggregation and de-aggregated events as required, regardless of component hierarchy

Acsis also will provide seamless, pre-built integration with SAP Auto-ID Infrastructure (AII) and Object Event Repository (OER) to share and track real-time product data throughout the supply chain.

"We are proud to partner with Daiichi Sankyo on this important project," said Neil Thall , Acsis CEO. "The Acsis serialization solution provides pharmaceutical companies with the necessary compliance capabilities to ensure consumer safety, in addition to establishing a foundation for achieving product visibility in the warehouse and across the supply chain."

About Daiichi Sankyo Inc.
The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit

About Acsis Inc.
Acsis is the market leader for Enterprise Serialization in the Pharmaceutical, Food & Beverage and Industrial markets. With 30 years of proven experience and industry expertise, Acsis offers the only serialization solution that gives customers complete control to track and trace products throughout the supply chain to meet mandates, gain visibility and improve productivity, while reducing chargebacks and counterfeiting. For more information, visit

Renee Truttman
Acsis, Inc.

SOURCE Acsis Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Both Biosimilar and Reference Biologics Companies Must consider Various Product-Specific and Regional Strategies to Navigate a Dynamic and Uncertain Global Market
2. Water Street Invests in Global Pharmaceutical Services Company
3. Equatorial Guineas [EG] Ministry of Health convenes in Washington, DC with GB Group Global and TNI Biotech (OTCBB:TNIB) to launch major innovative health solutions and improve pharmaceutical quality for its citizens
4. BioClinica, Inc. to Demonstrate Technology-Enhanced Capabilities at Upcoming Global Industry Events
5. Research and Markets Announces the Release of Cellulose Ethers Market By Derivative & Application - Global Trends & Forecasts to 2017
6. IRIDEX Announces Global Distribution and Supply Agreement with Peregrine Surgical, Ltd.
7. Work around the Clock: How Global Virtual Teams Are Re-Defining the Productivity Paradigm for Leading Companies
8. G-CON Manufacturing and Howorth Air Technology Announce Global Collaboration
9. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
10. Galderma, One of the Leading Pharmaceutical Companies, Relies on Verizon Enterprise Solutions to Provide Expanded, Secure Global Communications Platform
11. Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
Post Your Comments:
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):